333 related articles for article (PubMed ID: 16380437)
1. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.
Wang X; Kua HY; Hu Y; Guo K; Zeng Q; Wu Q; Ng HH; Karsenty G; de Crombrugghe B; Yeh J; Li B
J Cell Biol; 2006 Jan; 172(1):115-25. PubMed ID: 16380437
[TBL] [Abstract][Full Text] [Related]
2. p53 control of bone remodeling.
Liu H; Li B
J Cell Biochem; 2010 Oct; 111(3):529-34. PubMed ID: 20589754
[TBL] [Abstract][Full Text] [Related]
3. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis.
Rasheed N; Wang X; Niu QT; Yeh J; Li B
Hum Mol Genet; 2006 Jun; 15(12):1938-48. PubMed ID: 16644862
[TBL] [Abstract][Full Text] [Related]
4. A role for cell-surface CSF-1 in osteoblast-mediated osteoclastogenesis.
Yao GQ; Sun BH; Weir EC; Insogna KL
Calcif Tissue Int; 2002 Apr; 70(4):339-46. PubMed ID: 12004339
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis.
Seul KJ; Cho HS; Heo SH; Baek WY; Kim JE; Park EK; Choi JY; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Feb; 26(2):341-50. PubMed ID: 20715187
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast-osteoblast communication.
Matsuo K; Irie N
Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
Winslow MM; Pan M; Starbuck M; Gallo EM; Deng L; Karsenty G; Crabtree GR
Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
[TBL] [Abstract][Full Text] [Related]
9. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
10. Phosphate decreases osteoclastogenesis in coculture of osteoblast and bone marrow.
Takeyama S; Yoshimura Y; Deyama Y; Sugawara Y; Fukuda H; Matsumoto A
Biochem Biophys Res Commun; 2001 Apr; 282(3):798-802. PubMed ID: 11401534
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
12. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism.
Thommesen L; Stunes AK; Monjo M; Grøsvik K; Tamburstuen MV; Kjøbli E; Lyngstadaas SP; Reseland JE; Syversen U
J Cell Biochem; 2006 Oct; 99(3):824-34. PubMed ID: 16721825
[TBL] [Abstract][Full Text] [Related]
14. PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts.
Ali MM; Yoshizawa T; Ishibashi O; Matsuda A; Ikegame M; Shimomura J; Mera H; Nakashima K; Kawashima H
J Cell Sci; 2007 Aug; 120(Pt 15):2565-73. PubMed ID: 17623776
[TBL] [Abstract][Full Text] [Related]
15. Sp7/Osterix up-regulates the mouse pro-alpha3(V) collagen gene (Col5a3) during the osteoblast differentiation.
Yun-Feng W; Matsuo N; Sumiyoshi H; Yoshioka H
Biochem Biophys Res Commun; 2010 Apr; 394(3):503-8. PubMed ID: 20206127
[TBL] [Abstract][Full Text] [Related]
16. Bcl6 promotes osteoblastogenesis through Stat1 inhibition.
Fujie A; Funayama A; Miyauchi Y; Sato Y; Kobayashi T; Kanagawa H; Katsuyama E; Hao W; Tando T; Watanabe R; Morita M; Miyamoto K; Kanaji A; Morioka H; Matsumoto M; Toyama Y; Miyamoto T
Biochem Biophys Res Commun; 2015 Feb; 457(3):451-6. PubMed ID: 25597995
[TBL] [Abstract][Full Text] [Related]
17. Amelogenin is a negative regulator of osteoclastogenesis via downregulation of RANKL, M-CSF and fibronectin expression in osteoblasts.
Nishiguchi M; Yuasa K; Saito K; Fukumoto E; Yamada A; Hasegawa T; Yoshizaki K; Kamasaki Y; Nonaka K; Fujiwara T; Fukumoto S
Arch Oral Biol; 2007 Mar; 52(3):237-43. PubMed ID: 17101114
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human estrogen receptor alpha F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells.
Longo M; Peruzzi B; Fortunati D; De Luca V; Denger S; Caselli G; Migliaccio S; Teti A
J Mol Endocrinol; 2006 Dec; 37(3):489-502. PubMed ID: 17170089
[TBL] [Abstract][Full Text] [Related]
19. Osteoblast differentiation in vitro and in vivo promoted by Osterix.
Fu H; Doll B; McNelis T; Hollinger JO
J Biomed Mater Res A; 2007 Dec; 83(3):770-8. PubMed ID: 17559111
[TBL] [Abstract][Full Text] [Related]
20. p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix.
Wang X; Goh CH; Li B
Endocrinology; 2007 Apr; 148(4):1629-37. PubMed ID: 17185377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
